Allergenis
AllerGenis: Precision data analytics for detecting & managing immune disorders, with a focus on food allergies.
Founded
2017AllerGenis: Precision data analytics for detecting & managing immune disorders, with a focus on food allergies.
AllerGenis is a precision data analytics company founded with the mission to revolutionize the detection and management of life-threatening immune response disorders, particularly food allergies. Leveraging the world’s largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes, AllerGenis aims to provide healthcare providers with accurate, data-driven diagnostics. Their primary product focuses on redefining food allergy testing, starting with peanut allergies, to offer more precise and safer diagnostic solutions.
Notable figures affiliated with AllerGenis include leading experts in immunology and data science, though specific names are not provided. The company has attracted significant interest from investors focused on healthcare innovation. Key achievements include the development of their advanced diagnostic platform and the successful integration of extensive patient data to enhance clinical insights. AllerGenis has made a substantial impact by improving the accuracy of food allergy diagnoses, thereby enhancing patient care and safety.
Companies similar to Allergenis include Alerje, IngateyGen, Alladapt Immunotherapeutics and Allergy Amulet.
Allergenis was founded in 2017.
Allergenis' headquarters is located in Hatfield, PA, US.
Allergenis' most recent funding round was for $15M (USD) in November 2017.
As of Nov 1, 2017, Allergenis has disclosed funding of $15M (USD). Undisclosed round amounts are excluded.
Allergenis has 38 employees as of Feb 5, 2024.
Allergy Amulet
allergyamulet.com
